In Santulli et al. (1), leak from the sarcoplasmic reticulum (SR) is presented as a cause of mitochondrial dysfunction that contributes to heart failure (HF). The authors provide evidence in support of this provocative and important hypothesis. The strength of this paper comes primarily from the suggestions it provides that associate maladaptive changes of key physiological signaling pathways in the heart with the development of HF. A secondary benefit of the work is the array of questions related to the findings of the authors raised by them and provoked by other recent reports (discussed below).
In Santulli et al.
(1), RyR2-dependent Ca 2+ leak from the sarcoplasmic reticulum (SR) is presented as a cause of mitochondrial dysfunction that contributes to heart failure (HF). The authors provide evidence in support of this provocative and important hypothesis. The strength of this paper comes primarily from the suggestions it provides that associate maladaptive changes of key physiological signaling pathways in the heart with the development of HF. A secondary benefit of the work is the array of questions related to the findings of the authors raised by them and provoked by other recent reports (discussed below).
The thinking is that RyR2-based SR Ca 2+ leak increases in HF and thereby produces a pathologically elevated mitochondrial matrix
] m ) level along with excessive mitochondria reactive oxygen species (ROS) production (1). Together these elements form a causal chain in the development of HF following myocardial infarction (MI). With this argument, the paper throws down the gauntlet to the scientific community, challenging investigators to determine quantitatively how these elements interact to produce HF. Such investigations, armed with a growing arsenal of novel tools, hold an exciting potential for us to better understand cellular, organellar, and molecular dysfunctions that underlie the development of HF. Specifically, we need to understand how the transformation from healthy myocyte to dysfunctional myocyte occurs. The quantitative aspects of this process are critical because under normal conditions only modest increases in [Ca 2+ ] m are required to regulate ATP production (2) (3) (4) . Similarly, small amounts of ROS generation are a normal part of ATP generation by the electron transport chain (ETC) (5). To distinguish physiologic regulation from maladaptive pathophysiologic changes in [Ca 2+ ] m and ROS generation in HF, molecular details of the changes must be investigated quantitatively with good temporal resolution. Furthermore, there are no a priori reasons to believe that all of the changes in cardiac function in HF are primarily mitochondrial-centric, even in the MI model of HF presented by Santulli et al. (1). Alterations in activation, production, and degradation of many parallel cytosolic proteins and processes will almost certainly occur even when HF is associated with leaky RyR2s.
Santulli et al. (1) thus identify SR-mitochondrial interactions mediated by Ca
2+ that contribute to HF (Fig. 1) . Teasing apart the quantitative molecular and cellular details of the development of HF due to this dynamic and spatially resolved process is a huge task. Here we outline a simplified "challenge of Santulli" that arises from the PNAS paper and from a treasure trove of recent, exciting, perplexing, and sometimes contradictory reports on the molecular and cellular nature of mitochondrial Ca 2+ signaling in heart and elsewhere. These studies involve the mitochondrial Ca 2+ uniporter (6) (7) (8) , the mitochondrial sodium-calcium exchanger (NCLX or mNCX) (9, 10), the mitochondrial permeability-transition pore (mPTP) (11) (12) (13) , and an array of mitochondrialcentric functions (ranging from the ETC to ATP synthase and more), each of which may be involved with or contribute to the development of HF.
Here we present five questions that if addressed quantitatively may link Ca 2+ signaling and RyR2 leakiness to cardiac metabolic regulation and HF. Fig. 1A outlines graphically the location and function of key players in mitochondrial dynamics. Fig. 1B shows changes that may occur in WT control heart cells vs. experimental S2808D cells with leaky RyR2s. Critical aspects of the transition from control through MI to HF are highlighted. With the issues now identified and the availability of new tools, the time is ripe for these questions to be addressed. ] m increases when RyR2s become leaky, additional changes must be occurring and these need to be identified and measured quantitatively. Question 2. How and why does mitochondrial ROS increase in HF? To determine this, a host of things must be measured including metabolic substrate, redox state in mitochondria and in the cytosol, partial pressure of O 2 , ATP and ADP levels, the potential across the inner membrane (ΔΨ m ), and more. Additionally, nonmitochondrial ROS sources should be measured. By knowing what cellular processes change and when they change in relationship to the ROS production, it should be possible to understand mechanistically HF changes and the possible role of increases in ROS production. (17), are the S2808D cardiomyocytes more prone to mPTP activation and the corresponding cell injury? Alternatively, under such conditions, does mPTP activation have an inverse (i.e., ameliorating) (18) effect by purging the mitochondria of excess Ca
2+
, and therefore sustaining mitochondrial metabolism? Furthermore, can these measurements help us to determine the molecular identity of mPTP?
Question 5. What cellular changes exacerbate the damage caused by MI and drive cellular maladaptation leading to terminal HF? The cellular manifestations of HF develop as a maladaptation by the noninfarcted heart cells following the initial insult. Presumably, this response is a consequence of the stress created by the loss of previously healthy and functional tissue. Just as "orphan RyR2s" develop due to the reorganization of the transverse tubules in pressure-overload HF (19) (20) (21) , so too does this happen following MI in human and model disease (22) . Thus, the development of cellular and mitochondrial dysfunction following MI seems to depend on the consequences of the initiating insult, which include changes in Ca 2+ signaling as well as changes to the cellular cytoskeleton, both of which may alter cellular structure and mitochondrial behavior (23) .
The cellular and molecular understanding developed by answering question 5 should inform our view of the response of SR Ca 2+ leakiness and mitochondrial behavior to MI.
Although we appreciate that there are many other critical features in HF and mitochondrial biology that cannot be addressed here, this very brief perspective may help to clarify how an exciting set of present (1) and future work may be linked and thereby contribute to a broader understanding of heart and mitochondrial biology.
